Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GENE - Genetic Tech expects Q2 cash receipts of A$1.8M

GENE - Genetic Tech expects Q2 cash receipts of A$1.8M

Genetic Technologies Ltd
Genetic Technologies (NASDAQ:GENE) expects cash receipts for Q2 of A$1.8M, a 112% increase sequentially following the integration of EasyDNA. In the coming quarters, the focus will be on further leveraging the acquisition by including the Multi-Test product. Multi-Test technical validation submitted to regulators National Association of Testing Authorities and Centers for Medicare & Medicaid Services for final approval ahead of its commercial release. The company is now focused on finalizing commercial distribution opportunities via its EasyDNA brand and its existing partner network with IBX, 1 Health and Vitagene.

For further details see:

Genetic Tech expects Q2 cash receipts of A$1.8M
Stock Information
Company Name: Genetic Technologies Ltd
Stock Symbol: GENE
Market: NASDAQ
Website: gtglabs.com
Menu
GENE GENE Quote GENE Short GENE News GENE Articles GENE Message Board
Get GENE Alerts

News, Short Squeeze, Breakout and More Instantly...